Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial.
Atreja A, Khan S, Rogers JD, Otobo E, Patel NP, Ullman T, Colombel JF, Moore S, Sands BE; HealthPROMISE Consortium Group. Atreja A, et al. Among authors: colombel jf. JMIR Res Protoc. 2015 Feb 18;4(1):e23. doi: 10.2196/resprot.4042. JMIR Res Protoc. 2015. PMID: 25693610 Free PMC article.
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
Roblin X, Boschetti G, Williet N, Nancey S, Marotte H, Berger A, Phelip JM, Peyrin-Biroulet L, Colombel JF, Del Tedesco E, Paul S, Flourie B. Roblin X, et al. Among authors: colombel jf. Aliment Pharmacol Ther. 2017 Jul;46(2):142-149. doi: 10.1111/apt.14106. Epub 2017 Apr 27. Aliment Pharmacol Ther. 2017. PMID: 28449228 Clinical Trial.
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
Sabino J, Tarassishin L, Eisele C, Hawkins K, Barré A, Nair N, Rendon A, Debebe A, Picker M, Agrawal M, Stone J, George J, Legnani P, Maser E, Chen CL, Thjømøe A, Mørk E, Dubinsky M, Hu J, Colombel JF, Peter I, Torres J. Sabino J, et al. Among authors: colombel jf. J Crohns Colitis. 2023 Nov 24;17(11):1723-1732. doi: 10.1093/ecco-jcc/jjad096. J Crohns Colitis. 2023. PMID: 37279927
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA. Melmed GY, et al. Among authors: colombel jf. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1302-9. doi: 10.1016/j.cgh.2016.05.010. Epub 2016 May 14. Clin Gastroenterol Hepatol. 2016. PMID: 27189916
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry.
Itzkowitz SH, Jiang Y, Villagra C, Colombel JF, Sultan K, Lukin DJ, Faleck DM, Scherl E, Chang S, Chen L, Katz S, Kwah J, Swaminath A, Petralia F, Sharpless V, Sachar D, Jandorf L, Axelrad JE; New York Crohn’s and Colitis Organization. Itzkowitz SH, et al. Among authors: colombel jf. Clin Gastroenterol Hepatol. 2024 May 18:S1542-3565(24)00479-8. doi: 10.1016/j.cgh.2024.05.006. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38768673
Haematopoietic stem-cell transplantation in Crohn's disease.
Gupta A, Guisado D, Ricart E, Colombel JF, Cohen L. Gupta A, et al. Among authors: colombel jf. Lancet Gastroenterol Hepatol. 2024 Jun;9(6):499-500. doi: 10.1016/S2468-1253(24)00055-4. Lancet Gastroenterol Hepatol. 2024. PMID: 38734002 No abstract available.
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply.
Aliu A, Bosch DHCA, Keszthelyi D, Ardabili AR, Colombel JF, Sawyer R, Törnblom H, Hart A, Jonkers DMAE, Pierik MJ, Mujagic Z. Aliu A, et al. Among authors: colombel jf. Aliment Pharmacol Ther. 2024 Jun;59(12):1646-1647. doi: 10.1111/apt.18031. Epub 2024 May 10. Aliment Pharmacol Ther. 2024. PMID: 38726864 No abstract available.
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.
Canales-Herrerias P, Uzzan M, Seki A, Czepielewski RS, Verstockt B, Livanos AE, Raso F, Dunn A, Dai D, Wang A, Al-Taie Z, Martin J, Laurent T, Ko HM, Tokuyama M, Tankelevich M, Meringer H, Cossarini F, Jha D, Krek A, Paulsen JD, Taylor MD, Nakadar MZ, Wong J, Erlich EC, Mintz RL, Onufer EJ, Helmink BA, Sharma K, Rosenstein A, Ganjian D, Chung G, Dawson T, Juarez J, Yajnik V, Cerutti A, Faith JJ, Suarez-Farinas M, Argmann C, Petralia F, Randolph GJ, Polydorides AD, Reboldi A, Colombel JF, Mehandru S. Canales-Herrerias P, et al. Among authors: colombel jf. Sci Immunol. 2024 Apr 19;9(94):eadg7549. doi: 10.1126/sciimmunol.adg7549. Epub 2024 Apr 19. Sci Immunol. 2024. PMID: 38640252
Microbiota therapeutics for inflammatory bowel disease: the way forward.
Bethlehem L, Estevinho MM, Grinspan A, Magro F, Faith JJ, Colombel JF. Bethlehem L, et al. Among authors: colombel jf. Lancet Gastroenterol Hepatol. 2024 May;9(5):476-486. doi: 10.1016/S2468-1253(23)00441-7. Lancet Gastroenterol Hepatol. 2024. PMID: 38604201 Review.
1,124 results